Box score
Aclaris Therapeutics, Inc.
Reported $80M sold in a new Form D filed December 4, 2024 (Wayne, Pennsylvania).
- Biggest raise
- $80M filed Dec 4, 2024
- League
- Bio & Health Pharmaceuticals
- Based in
- Wayne, Pennsylvania
- Season rank
- #67 of 1,389 in the Bio & Health League; #255 of 12,443 overall (2024)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-12-04 | New notice | $80M | $80M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1557746.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Context Therapeutics Inc. rookie | Bio & Health | $100M |
| 2 | Third Arc Bio, Inc. rookie | Bio & Health | $72.5M |
| 3 | Interius BioTherapeutics, Inc. | Bio & Health | $51.4M |
| 4 | Cagent Vascular, Inc. | Bio & Health | $28.7M |
| 5 | PeopleOne Health, Inc. | Bio & Health | $23.7M |
| 6 | Reunion Neuroscience Management, Inc. rookie | Bio & Health | $16.9M |